Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT)

BACKGROUND: Oncolytic virotherapy with vaccinia virus (VV) can lead to effective anti-tumor immunity by turning “cold” tumors into “hot” tumors. However, its therapeutic potential is affected by the tumor's local immunosuppressive tumor microenvironment (TME). Therefore, it is necessary to expl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Shuguang, Wei, Min, He, Bohao, Chen, Anxian, Wang, Shiqun, Kong, Lingkai, Zhang, Yenan, Meng, Gang, Xu, Tiancheng, Wu, Jingyi, Yang, Fuming, Zhang, Hailin, Wang, Shibing, Guo, Ciliang, Wu, Junhua, Dong, Jie, Wei, Jiwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878184/
https://www.ncbi.nlm.nih.gov/pubmed/33581644
http://dx.doi.org/10.1016/j.ebiom.2021.103240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878184/
https://www.ncbi.nlm.nih.gov/pubmed/33581644
http://dx.doi.org/10.1016/j.ebiom.2021.103240

Ejemplares similares